I’m buying this 9p penny stock till I’m blue in the face!

Our writer thinks penny stock, Agronomics (LSE:ANIC), could be set for explosive growth over the next few years. And he’s putting his money on it.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Stacks of coins

Image source: Getty Images

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Agronomics (LSE: ANIC) is a penny stock I’ve been buying on dips for some time now. Today, it is trading at 9p, giving the company a market cap of £93m.

Here’s why I’m loading up.

Agro…what?

For those unfamiliar, Agronomics is a venture capital firm that invests in the rising industry of cellular agriculture and cultivated meat.

This is the production of animal products from cells rather than entire animals. And the meat is produced by in vitro cultivation of animal cells rather than from slaughtered animals.

The firm has provided seed and early-stage funding to various start-ups. Here are some of those and what they focus on.

COMPANYPRODUCT
SuperMeatLab-grown chicken
VitroLabsLab-grown leather
FormoAnimal-free dairy
BlueNaluLab-grown seafood
MeatableLab-grown pork and beef
EveryChicken-less eggs

Is there a need for this technology?

Around 2trn fish are caught each year for human consumption, and many species are now close to being overfished. Yet, as the global population grows, ocean fishing is expected to increase .

I’m no expert, but that doesn’t sound sustainable to me. Put bluntly, overfishing could eventually empty the oceans, with catastrophic ecological consequences.

Fortunately, viable technologies have now emerged that could provide a solution. Cells taken from animals can be immortilised, meaning they can grow indefinitely. This allows for large-scale quantities of meat to be produced from a single biopsy.

Food security

Following the war in Ukraine, which caused food supply chain problems and inflation, nations are desperate to bolster their food security.

Hence why President Joe Biden signed an executive order last year backing new technologies like cellular agriculture.

He said these can be used “to achieve our climate and energy goals, improve food security and sustainability, secure our supply chains, and grow the economy across all of America”.

Portfolio progress

Agronomics recently announced that BlueNalu has raised $33.5m in a series B financing round. This firm is a pioneer in cellular aquaculture, which involves taking living cells from fish tissue to produce fresh and frozen seafood products.

It plans to launch its first commercial product — a lab-grown premium bluefin tuna toro — following regulatory approval.

For Agronomics, this latest financing round represents a two-times multiple of invested capital. This is highly encouraging as it proves the firm is capable of identifying early-stage opportunities in this space.

It now owns 5.12% of BlueNalu and it makes up about 8% of the portfolio. Agronomics is set to profit handsomely if this (or any other) firm one day goes public or is acquired, . That’s the aim here.

Foolish takeaway

The firm’s net asset value (NAV) per share was 15.8p on 30 June. At 9p, that means the shares are trading at a 41% discount to NAV. In response, the board has launched a £3m share buyback programme.

Is the stock a bargain at 9p then? I think so, though that discount could widen further if investor sentiment around unlisted assets continues to deteriorate. That’s a risk here.

On the other hand, cellular agriculture could represent the biggest change in food production since the first domestication of plants and animals 10,000 years ago.

If so, it could be the largest mega-trend this century. And Agronomics provides a unique way to invest in it. This is why I’m buying shares at 9p.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Ben McPoland has positions in Agronomics. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Surely, the Rolls-Royce share price can’t go any higher in 2025?

The Rolls-Royce share price was the best performer on the FTSE 100 in 2023 and so far in 2024. Dr…

Read more »

A young woman sitting on a couch looking at a book in a quiet library space.
Investing Articles

Here’s how an investor could start buying shares with £100 in January

Our writer explains some of the things he thinks investors on a limited budget should consider before they start buying…

Read more »

Investing Articles

Forget FTSE 100 airlines! I think shares in this company offer better value to consider

Stephen Wright thinks value investors looking for shares to buy should include aircraft leasing company Aercap. But is now the…

Read more »

Investing Articles

Are Rolls-Royce shares undervalued heading into 2025?

As the new year approaches, Rolls-Royce shares are the top holding of a US fund recommended by Warren Buffett. But…

Read more »

Investing Articles

£20k in a high-interest savings account? It could be earning more passive income in stocks

Millions of us want a passive income, but a high-interest savings account might not be the best way to do…

Read more »

Investing Articles

3 tried and tested ways to earn passive income in 2025

Our writer examines the latest market trends and economic forecasts to uncover three great ways to earn passive income in…

Read more »

Investing Articles

Here’s what £10k invested in the FTSE 100 at the start of 2024 would be worth today

Last week's dip gives the wrong impression of the FTSE 100, which has had a pretty solid year once dividends…

Read more »

Investing Articles

UK REITs: a once-in-a-decade passive income opportunity?

As dividend yields hit 10-year highs, Stephen Wright thinks real estate investment trusts could be a great place to consider…

Read more »